Products & Technologies (587 News)

AstraZeneca provides Update on GALATHEA Phase III Trial for Fasenra in Chronic Obstructive Pulmonary Disease

Oct 10, 2018 9:00 am
445
Views
0
Comments

AstraZeneca and MedImmune, its global biologics research and development arm, today announced top-line results from the GALATHEA Phase III trial fo...

Merck’s Paired CRISPR Nickases Technique can Help us to Correct Genetic Defects in Gene Therapy Patients

Sep 27, 2018 10:00 am
549
Views
0
Comments

Darmstadt, Germany, August 15, 2018 – Merck, the vibrant science and technology company, today announced that the Australian Patent Office has a...

The Advance in the DNA Nanotechnology Field

Sep 26, 2018 12:00 pm
544
Views
0
Comments

In the journal Nature Communications, Carlos Castro and Ratnasingham Sooryakumar and their colleagues from The Ohio State University report that the c...

Lumoxiti, the First New Treatment Option for HCL's Patients in Over 20 Years

Sep 26, 2018 12:00 pm
643
Views
0
Comments

AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration (FDA) has appro...

Alecensa® is a New Roche's Drug as an Initial Treatment for ALK

Sep 23, 2018 10:00 am
532
Views
0
Comments

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the China National Drug Administration (CNDA) has granted marketing authorisation for Alecensa...

Meet CRISPR-SKIP New Technology

Sep 6, 2018 10:00 am
988
Views
0
Comments

In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell's internal machinery ...

New High Potential Mass Spectrometry Technology

Aug 15, 2018 12:00 pm
866
Views
0
Comments

New mass spectrometry technology, accessories and software will be brought to you at the ASMS conference in San Diego. During ASMS 2018 in San...

For The First Time: New Device that can Isolate Fetal cells from Maternal Blood Cells.

Aug 5, 2018 12:00 pm
762
Views
0
Comments

A small microfluidic device that can separate maternal and fetal cells is being developed to detect genetic abnormalities in early pregnancy through n...

RETACRIT® is the First and only Bio similar Erythropoiesis Stimulating Agent Approved in U.S.from Pfizer

Jul 30, 2018 11:00 am
711
Views
0
Comments

Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) approved RETACRIT® (epoetin alfa-epbx), a biosi...

The New Thermo Scientific Krios Cryo-TEM Electron Microscope Unveiled by the Institut Pasteur

Jul 25, 2018 10:00 am
965
Views
0
Comments

HILLSBORO, Ore., July 12, 2018 /PRNewswire/ -- The Institut Pasteur officially unveiled its new Thermo Scientific Krios Cryo-TEM electron microscope a...

A New Precision Medicine Science Center (PMSC) fromThermo Fisher Scientific to Facilitate Access to Modern Technologies

Jul 24, 2018 10:00 am
527
Views
0
Comments

BOSTON—Thermo Fisher Scientific has opened its U.S. Precision Medicine Science Center (PMSC) in neighboring Cambridge, MA, with a focus on ad...

Merck’s Supplemental Biologics License Application for KEYTRUDA in Combination with Chemotherapy is granted FDA Priority Review

Jul 23, 2018 10:00 am
676
Views
0
Comments

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Ad...

The OncoDNA Project Aims to Validate the Unique SaaS Drug Program

Jul 17, 2018 11:00 am
1020
Views
0
Comments

OncoDNA (“OncoDNA or “the Company”), the healthcare technology company making precision medicine a reality, provides an update today...

ThermoFisher Scientific Company Donate 1 Million$ Worth of Rapid DNA Analyzers

Jul 16, 2018 10:00 am
727
Views
0
Comments

Thermo Fisher Scientific, the world leader in serving science, announced it is offering to donate $1 million worth of rapid DNA analyzers and re...

Aproval of First Artificial Iris to Treat Iris Defects that Reduce Sensitivity to Bright Light and glare

Jul 15, 2018 4:00 pm
579
Views
0
Comments

The US Food and Drug Administration (FDA) has approved the first artificial iris for use in adults and children with congenital aniridia or iris defec...

New Information on Hiv-1 Treatment Offered by Merck at the 22nd AIDS Conference

Jul 11, 2018 10:00 am
583
Views
0
Comments

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that new data from the compan...

BioTek Invents a New Automatic Microscope " Lionheart™ LX "

Jul 10, 2018 9:00 am
593
Views
0
Comments

February 16, 2018, WINOOSKI VT, USA — BioTek makes it even easier for laboratories to transition into automated digital microscopy with the new,...

A New Multi-Mode Microplate Reader from BioTek

Jul 9, 2018 11:00 am
434
Views
0
Comments

May31, 2018, WINOOSKI VT, USA —BioTek introduces the affordable, user-friendly Synergy™ LX Multi-Mode Microplate Reader to automate the mo...

The Global Biopharmaceutical Company AbbVie will Present Data from Clinical trials of the first-in-class oral B-cell lymphoma-2 (BCL-2) inhibitor

Jul 1, 2018 9:00 am
369
Views
0
Comments

NORTH CHICAGO, Ill., May 31, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced it will pres...

QIAGEN Launches New QIAseq 16S Panels and UCP Multiplex PCR Kit Enabling Unbiased Microbiome Profiling

Jun 28, 2018 8:00 pm
552
Views
0
Comments

Germantown, Maryland, and Hilden, Germany, June 7, 2018 – QIAGEN today announced the launch of the QIAseq 16S/ITS Panels and UCP Multiplex PC...


< 1 2 3 4 5 6 7 8 9